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The Mini-Mental State Examination (MMSE) has been criticized as an insufficient screening test for 
patients with vascular cognitive impairment due to insensitivity to visuospatial and executive functional 
deficits. The Montreal Cognitive Assessment (MoCA) was designed to be more sensitive to such deficits 
and may therefore be a superior screening instrument for vascular cognitive impairment. 
 
Methods: 
Twelve patients with extensive leukoaraiosis on magnetic resonance imaging (76.0±8.7 yrs on average) 
underwent neurological and cognitive measures, including the Japanese version of MoCA (MoCA-J) and 
MMSE. Accepted cutoffs of MMSE <27 and MoCA <26 were taken to indicate cognitive impairment. Z 




Although there was a strong correlation between the total MoCA-J and MMSE scores (r=0.90, p<0.0001), 
MMSE scores were skewed toward the higher scores (range 18-30, median 28), while MoCA-J scores 
3 
 
were normally distributed (range 9-28, median 21). Of the seven patients with unimpaired MMSE scores, 
six (86%) patients had an impaired MoCA-J score. Z scores were >5 for four MMSE subtests (orientation, 
registration, naming, and language) but for only one MoCA-J subtest (naming).  
 
Conclusions: 
The MoCA-J better discriminated cognitive status between subjects with extensive leukoaraiosis. 
MoCA-J is more sensitive than the MMSE in screening for cognitive impairment in patients with 
subcortical vascular cognitive impairment.  
 











Cognitive impairment resulting from cerebrovascular insufficiency has been termed vascular cognitive 
impairment (VCI).
1
 VCI forms a spectrum that includes mild cognitive impairment of vascular etiology 
(vascular MCI), vascular dementia, mixed Alzheimer’s disease with a vascular component.2, 3 As vascular 
MCI patients with more severe impairment were found to be at higher risk of conversion to dementia, 
compared to patients with less severe or no cognitive impairment,
4
 early detection of cognitive deficits 
may facilitate in preventing cognitive deterioration.  
 
The widely used Mini-Mental State Examination (MMSE)
5
 was found to be inaccurate in screening VCI 
as it was insensitive to MCI or complex cognitive deficits specifically.
1, 6
 By comparison, the Montreal 
Cognitive Assessment (MoCA) has been designed to be sensitive to mild deficits
7
 and has been evaluated 
in amnestic MCI
7
 and Parkinson disease
8
. Importantly, MoCA is reported to detect more cognitive 
abnormalities after ischemic stroke or transient ischemic attack, compared to MMSE, particularly in 
relation to executive function, attention and delayed recall.
9, 10
 In addition, the Hong Kong MoCA is 
reported to be useful for use in Chinese patients with leukoaraiosis;
11
 however, direct comparison of 




Hence, the primary aim of the present study was to test the hypothesis that MoCA is more sensitive than 
MMSE in the detection of cognitive impairment in patients with ischemic leukoaraiosis, namely 
subcortical VCI, which incorporates two clinical entities ‘Binswanger’s disease’ and ‘the lacunar state’. 
The feasibility and the psychometric properties of MoCA (modified for Japanese population; MoCA-J) 






Twelve patients whose FLAIR- and T2-weighted MRI scans revealed confluent hyperintensities in the 
subcortical white matter (Schmidt scale score of 3)
12
 and several punctate high-intensity areas in the basal 
ganglia were studied. The patients were enrolled because of the above neuroradiological abnormalities 
after visiting our Neurology Clinic from May 2008 to March 2011 with various neurologic signs and 
symptoms. Patients with mild to moderate leukoaraiosis (Schmidt scale score of 1 or 2) were not enrolled 
in this study to exclude the possibility of leukoaraiosis associated with neurodegenerative disorders, such 
as Alzheimer’s disease. Each subject was fully instructed on the experimental procedures and provided 
with written, informed consent, as approved by the Committee of Medical Ethics within our faculty. None 
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of the patients had apparent lesions in the cerebral cortex or hippocampus. MR angiography and duplex 
color-coded sonography did not reveal >50% stenosis in the major intracranial and extracranial vessels.  
 
Neuropsychological evaluation 
All subjects underwent a general physical and neurologic examination and neuropsychological 
assessment, including the MoCA-J and MMSE. To avoid habituation and interference effects, MMSE was 
carried out at least one week after MoCA-J assessment. Two neurologists were involved in the 
neuropsychological assessment; if their assessments did not correlate, patients were reexamined by the 
team for a final verdict. A cutoff of ≧27 on MMSE score was chosen to indicate normal cognitive 
function
13




The Z score analysis 
For both the MMSE and MoCA-J subtests, the Z scores were calculated by dividing the mean subtest 
score by its standard deviation, where lower Z scores indicate greater discrimination between subjects. 
 
Statistical analysis 
The statistical significance of intergroup differences was assessed with Fisher’s exact test for categorical 
variables, and continuous variables of demographic data by the Mann-Whitney U test. Possible links 
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Demographic data of the patients 
Patient clinical features and demographics are summarized in the Table 1. All patients had at least 1 risk 
factor for ischemic cerebrovascular disease, including hypertension and diabetes mellitus. Eight of 12 
patients (67%) showed gait disturbance, the most frequent neurological deficit. The mean modified 
Rankin Scale score was 1.4 (range, 1–2). Most of the patients showed lacunar infarctions or microbleeds 
in the basal ganglia or the thalamus as a manifestation of underlying small vessel pathology. Their clinical 
histories and radiological features excluded possibility of co-existing single-strategic infarct dementia.  
 
Relationship between MoCA-J and MMSE scores 
There was a significant relationship between the MoCA-J and MMSE scores (r=0.90, p<0.0001). MMSE 
scores were skewed toward the higher scores (range 18–30, median 28) while MoCA-J scores were 
normally distributed (range 9–28, median 21) (Figure 1). Of the 11 patients with impaired MoCA-J scores, 
only five (45%) patients had an impaired MMSE score, while all 11 patients with impaired MMSE scores 
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had an impaired MoCA-J score. Of the seven patients with unimpaired MMSE scores, six (86%) had an 
impaired MoCA-J score.  
 
Z score analysis 
Individual subtests of the MMSE and MoCA-J, together with the results, are described in Table 2 and 
Table 3, respectively. Z scores were >5 for four MMSE subtests (orientation, registration, naming, and 
language) but only for one MoCA-J subtest (naming).  
 
Clinical utility of the MoCA-J 
The MoCA-J was accomplished by all the Japanese elderly subjects with VCI enrolled in this study. The 
average administration time was 12 minutes. 
 
Correlation analysis between the MoCA-J score and the MRI-based cerebrovascular lesions 
The MoCA-J score was significantly correlated with the number of lacunar infarctions (r=−0.67, p=0.03) 






The main finding of this study is that MoCA-J is more sensitive than the MMSE in detecting subcortical 
VCI. Eleven of the 12 patients with either impaired MoCA-J or MMSE scores could only be detected by 
impaired MoCA-J scores, while none of the patients presented with only impaired MMSE scores. In 
addition, the Z score analysis suggested that the MoCA-J better discriminated cognitive status between 
subjects. Therefore, MoCA-J could be a useful instrument to detect VCI at an earlier stage in patients 
with extensive leukoaraiosis. The significant correlation of the MoCA-J score with the number of lacunar 
infarctions further suggests the clinical relevance of this screening test in the detection of VCI 
characterized by small vessel pathology. It took only 12 minutes to administer the MoCA-J even in 
subcortical VCI patients.  
 
The poorer performance of the MMSE in detecting subcortical VCI may be due to several factors. The 
MMSE is less sensitive in detecting impairment in visuospatial or executive function, characteristic 
features that are preferentially impaired in VCI.
2, 15
 In light of such restrictions of MMSE, the 
trail-making test or digit symbol test has been recommended to supplement the MMSE to improve its 
sensitivity in the cognitive assessment of subjects with leukoaraiosis.
16
 Furthermore, visuo-executive 
dysfunction has been found to predict poor survival after stroke;
17
 therefore, early detection of VCI with 
MoCA is ideal for earlier initiation of intervention and improved outcome. Vascular risk factors should be 
adequately controlled to achieve a reduction in the risk of dementia.
18




The MoCA-J demonstrated deficits in other cognitive domains, such as recall and language. As the 
specific assessment criteria to test recall and language are less complicated in MMSE than in MoCA-J, 
the ceiling effect may prevent MMSE from detecting intersubject differences in cognitive impairment. In 
support of this, the Z scores for recall and language in MoCA-J were lower than those in MMSE, 
indicating higher discriminating power of MoCA-J in assessment of cognitive impairment.  
 
Recently, vascular risk factors have been reported to promote conversion from MCI to Alzheimer’s 
disease.
19
 Moreover, in patients who have clinically diagnosed Alzheimer’s disease, treatment of vascular 
risk factors is associated with a slower decline in MMSE score.
20
 A recent animal study has suggested 
that the effect of Alzheimer’s neurodegeneration and VCI are not only additive but also synergistic in 
worsening cognitive impairment.
21
 Therefore, the early diagnosis of amnestic MCI with MoCA
7, 14
 may 
also benefit patients by the introduction of optimal control of any vascular risk factors, which may 
prevent conversion of MCI to dementia.    
 
The main limitation is a small number of patients enrolled in this study as only those with most severe 
white matter changes were eligible for this study to minimize heterogeneity of VCI and to exclude those 





preliminary study should therefore be viewed as hypothesis generating and should be followed by larger 
studies to confirm the results. Nevertheless, our study provided a direct comparison of MMSE and 
MoCA-J, which showed an appreciably greater suitability of the MoCA-J against the MMSE in the 
detection of VCI. 
 
In conclusion, the MoCA-J is a promising tool for the screening for cognitive impairment in VCI patients 
with leukoaraiosis as it may detect complex cognitive impairments, such as in executive function and 
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Table 1. Patient clinical features and demographics 
 
Variable   
Mean age (range), y 76±8.7 (55–84) 
Gender M, 7; F, 5 
Modified Rankin Scale, mean score (range) 1.4±0.5 (1–2) 
Gait disturbance, No. (%) 8 (67) 
Dysarthria, No. (%) 4 (33) 
Urinary incontinence, No. (%) 3 (25) 
Hypertension, No. (%) 7 (58) 
Diabetes mellitus, No. (%) 3 (25) 
Cigarette smoking, No. (%) 3 (25) 
Sleep apnea, No. (%) 2 (17) 
Previous CVD, No. (%) 6 (50) 
Use of antithrombotics, No. (%) 8 (67) 
Use of statins, No. (%) 6 (50) 
LDL Cholesterol, mg/dL 115±44 
Triglyceride, mg/dL 112±45 
16 
 
Hematocrit, % 39.6±3.9 
Fibrinogen, mg/dL 286±53 
No. of MBs in the BG/thalamus 1.5±2.0 
No. of lacunas in the BG/thalamus 2.9±2.8 
 



















Naming/3 Attention/6 Language/3 Abstraction/2 Recall/5 Orientation/6 
Pt 1 1 2 4 1 1 0 5 
Pt 2 1 3 3 0 0 0 2 
Pt 3 3 3 6 1 2 3 6 
Pt 4 2 3 3 1 2 0 4 
Pt 5 3 2 6 2 1 4 5 
Pt 6 4 3 5 2 2 3 6 
Pt 7 3 3 6 1 1 2 6 
Pt 8 4 3 5 1 1 0 6 
Pt 9 2 3 6 2 2 0 6 
Pt 10 5 3 6 2 2 4 6 
Pt 11 3 3 5 1 0 0 5 
Pt 12 2 3 6 2 2 0 4 
Average 2.8  2.8  5.1  1.3  1.3  1.3  5.1  
SD 1.2  0.4  1.2  0.7  0.8  1.7  1.2  




MoCA-J domain subtest maximum score/details: visuo-executive/5 – trail B test, cube copy, clock 
drawing; attention/6 – digit span, vigilance (tapping at the Hiragana ‘a’ in a list of Hiragana characters), 
serials 7 s; recall/5 – recall a list of 5 words; orientation/6 – date, month, year, day, place, city; 
abstraction/2 – similarities between two items; language/3 – sentence repetition, verbal fluency; naming/3 















Table 3. Mean of MMSE subtest scores with different cognitive screening test results 
MMSE Orientation/10 Registration/3 
Attention/ 
Calculation/5 
Recall/3 Naming/2 Language/6 Drawing/1 
Pt 1 9 3 4 2 2 3 0 
Pt 2 5 2 4 0 1 5 1 
Pt 3 10 3 5 3 2 6 1 
Pt 4 10 3 1 0 2 5 1 
Pt 5 10 3 4 2 2 5 1 
Pt 6 10 3 5 2 2 6 1 
Pt 7 10 3 5 3 2 6 1 
Pt 8 10 3 4 0 2 6 1 
Pt 9 10 3 4 3 2 6 1 
Pt 10 10 3 5 3 2 6 1 
Pt 11 10 3 1 0 2 6 1 
Pt 12 9 3 5 3 2 6 1 
Average 9.4  2.9  3.9  1.8  1.9  5.5  0.9  
SD 1.4  0.3  1.4  1.4  0.3  0.9  0.3  




MMSE domain subtest maximum score / details: attention/calculation/5 – serial 7 s; recall/3 – recall a list 
of 3 words; orientation/10 – orientation to place and time; naming/2 – confrontation naming (pen, watch); 
language/6 – sentence repetition, comprehension, reading, writing; registration/3 – repeat 3 words; 

















Figure 1. Distribution of MoCA-J and MMSE scores of the patients with extensive leukoaraiosis. Cutoffs 
of MMSE <27 and MoCA-J <26 were taken to indicate cognitive impairment (dotted line).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
